Table 2.
GJ Compart. /GJ Networks |
Cellular Components |
Connexin Expression | Brain-Related Physiological Effects of Cx Deficiency in: | |||||
---|---|---|---|---|---|---|---|---|
Cell Types | Major Cell Functions | Cx Types (Major Cxs) |
Cx Functions | Principal Physiological Roles of Major Cxs |
Mice (Cx Knock out) |
Human (Cx Gene Defect) |
||
GJIC | HC | |||||||
Neuronal | Neurons | Action potential transmission | Cx36 [25,26,27] Cx31.1 [23,29] Cx45 [30,31,32] Cx57 [33,34,35] |
+ [27] |
+ [28] |
Electrical synapses (no synaptic delay): -Synchronization of interconnected neurons [27] -Excitability limitation in inhibitory networks [27] -Role in learning and memory [27] |
Single KO Cx36: -Impaired short- and long-term memories [36,37] -Reduced motor learning [36,37] |
Cx36: -Juvenile myoclonic epilepsy [38,39] |
Panglial syncytium | Astrocytes | -Component of neuronal synapses (tripartite synapses) -BBB component (astrocytic endfeet) |
Cx43 [40] Cx30 [40] Cx26 [41] |
+ [42] + [42] ? [43] |
+ [44] ? |
-Glucose/lactate diffusion from capillaries to neurons and panglial syncytium (oligo., ependym.) [45] -K+ diffusion from neuron periphery and oligo. to capillaries [46,47] -Synaptic clearing of neurotransmitters, diffusion and recycling towards neurons [45] -Modulation of neuronal activity [48] -BBB maturation [49] -Gliosis and modulation of neuron activity through Cx43 HC activated by IL-1β/TNF-α (neuroinflam.) [50,51] or Ca2+/K+ [52,53,54]. Such activation leads to ATP release leading to paracrine/GJIC-mediated IP3/Ca2+ wave propagation (gliosis) [55] and gliotransmitters (glutamate) release (synaptic modulation) [56] |
Single KO Cx43 (astro.): -Accelerated hippocampal spreading depression and enhanced locomotory activity [57] -Increased exploratory activity [58] -Anxiolytic-like effect in open field [58] Cx30: -Reduced exploratory activity -Anxiogenic behavior [59] Double KO Cx43 (astro.)/x30 [60]: -Vacuolated oligo. -Edematous astrocytes -Myelination abnormalities -Spatial memory impair -Sensimotor impair |
Cx43: ODDD patients (according to mutations) [61]: -White matter change -Psychomotor delay -Epilepsy -Language disorder |
Oligo. | -Axon myelination to facilitate propagation of action potentials |
Cx2 9[62] Cx32 [63] Cx47 [63] |
? [64] + [62,65,66,67] + [62,65,66,67] |
? [68] |
-Myelin integrity [69] -K+ buffering from neuron periphery to astrocytes [63,70] |
Single KO Cx29: -No myelin defect [71] Cx32 [72]: -Enhanced intrinsic excitability of neurons -Myelination defects in neocortex -Dysfunction of inhibitory synaptic transmission Cx47 [66]: -No behavior abnormality -Vacuolation of nerve fibers -Myelination abnormality Double KO Cx32/Cx47 [73]: -Myelination abnormality -Astrogliosis -Microglia activation Cx30/Cx47 [74]: -Myelination defects -Severe motor impairment -Decreased number of oligodendrocytes -Microglia activation |
Cx32: CMT1X patients: -Mostly peripheral neuropathy [75] -Encephalopathy linked to metabolic stress (white matter lesions) [76] Cx47: Pelizaeus-Merzbacher-like disease [77,78]: -Myelination abnormality -Impaired psychomotor development |
|
Ependym. | -Lining cerebral cavities -Restrictive barrier between cerebrospinal and interstitial fluids -Facilitate circulation of cerebrospinal fluid by ciliated cells |
Cx43 [79] |
+ [79] |
|||||
Vascular | Endo. cells | -Lining brain capillaries | Cx37 [80] Cx40 [80] Cx43 [80] |
+ + + |
-BBB integrity [81] -Maintenance and control of endothelial barrier function [81] |
Cx37 polymorphism: -Ischemic stroke risk? [82] |
||
Pericytes | -Regulation of blood flow through contraction capacity |
Cx37 [80] Cx40 [80] Cx43 [80] |
+ + + |
-Pericyte contraction? [83,84,85,86] -Maintenance of vascular homeostasis [81] |
||||
Other | Microglia | -Inflammation control -Phagocyte micro-organisms and damaged cells |
Cx32 [87] Cx36 [88] Cx43 [89] (When activated) |
? ? [88] (With neurons when activated) + [90,91] |
+ [87] + [92] |
-Neuron death [87] -Control of NPC proliferation, differentiation and migration [93,94,95,96,97] -Exchange of antigenic peptides? [98] |